Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance
Aim: Breast cancer-related lymphoedema (BCRL) is a disabling complication developing after breast cancer treatment in a proportion of patients. Its impact on quality of life becomes more substantial as survival after breast cancer diagnosis increases. The incidence of BCRL following breast cancer tr...
Main Authors: | , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Universa Press
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987359/ |
id |
pubmed-3987359 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-39873592014-04-21 Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance Göker, M. Devoogdt, N. Van de Putte, G. Schobbens, J.C. Vlasselaer, J. Van den Broecke, R. de Jonge, E.T.M. Systematic Review Aim: Breast cancer-related lymphoedema (BCRL) is a disabling complication developing after breast cancer treatment in a proportion of patients. Its impact on quality of life becomes more substantial as survival after breast cancer diagnosis increases. The incidence of BCRL following breast cancer treatment varies due to a lack of uniform definition and measurement criteria. This review aims to determine the prevalence of BCRL following axillary lymph node dissection (ALND) as a benchmark to be used in a risk-benefit medical decision whether to proceed with ALND or not. The risk of leaving unresected non-sentinel metastatic lymph nodes with a presumed inherent risk of local recurrence will be balanced against the risk of BCRL following a potentially unnecessary ALND. Universa Press 2013 /pmc/articles/PMC3987359/ /pubmed/24753936 Text en Copyright: © 2013 Facts, Views & Vision http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Göker, M. Devoogdt, N. Van de Putte, G. Schobbens, J.C. Vlasselaer, J. Van den Broecke, R. de Jonge, E.T.M. |
spellingShingle |
Göker, M. Devoogdt, N. Van de Putte, G. Schobbens, J.C. Vlasselaer, J. Van den Broecke, R. de Jonge, E.T.M. Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance |
author_facet |
Göker, M. Devoogdt, N. Van de Putte, G. Schobbens, J.C. Vlasselaer, J. Van den Broecke, R. de Jonge, E.T.M. |
author_sort |
Göker, M. |
title |
Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance |
title_short |
Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance |
title_full |
Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance |
title_fullStr |
Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance |
title_full_unstemmed |
Systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance |
title_sort |
systematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearance |
description |
Aim: Breast cancer-related lymphoedema (BCRL) is a disabling complication developing after breast cancer treatment in a proportion of patients. Its impact on quality of life becomes more substantial as survival after breast cancer diagnosis increases. The incidence of BCRL following breast cancer treatment varies due to a lack of uniform definition and measurement criteria. This review aims to determine the prevalence of BCRL following axillary lymph node dissection (ALND) as a benchmark to be used in a risk-benefit medical decision whether to proceed with ALND or not. The risk of leaving unresected non-sentinel metastatic lymph nodes with a presumed inherent risk of local recurrence will be balanced against the risk of BCRL following a potentially unnecessary ALND. |
publisher |
Universa Press |
publishDate |
2013 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987359/ |
_version_ |
1612078373056544768 |